Tissue regeneration technology developer Orthocell has received Food and Drug Administration approval to market its first product in the US, its CelGro Dental collagen device which aids dental bone and tissue regeneration. The Perth company announced the approval and a new brand name for the products, Striate+. Managing director Paul Anderson said CelGro would now…
Nerve technology developer Orthocell (ASX:OCC) has received a $2.9 million R&D tax incentive refund for the 2018/19 financial year. The Perth company, which is commercialising its CelGro product to facilitate the regeneration of severed peripheral nerves, will invest the funds to accelerate regulatory approvals and to advance R&D. The company also recently raised new capital…
Nerve technology developer Orthocell (ASX:OCC) has received firm commitments from institutional investors to raise $13 million in a share placement. The company, which is commercialising its CelGro nerve regeneration product, received commitments for well in excess of the figure sought from existing and new investors. The company will also proceed with a share purchase plan…
Nerve technology developer Orthocell (ASX:OCC) has reported a study validating ‘high quality nerve repair’ from its CelGro treatment. The pre-clinical study indicated CelGro facilitated the regeneration of severed peripheral nerves, returning them to normal nerve structure. This reinforces earlier human trials that CelGro restored nerve sensation, reducing the need for sutures. Orthocell managing director, Paul…
Titomic announces sale of TKF metal 3D printing systems 3d printer manufacturer Titomic has announced the sale of cold spray additive manufacturing systems and associated equipment to Spanish technology centre Fundacion Centre Technologico Miranda de Ebro (CTME). The sale includes D633 medium-pressure and D523 low-pressure cold spray systems, a powder feeder and integrated spray booth…
Austal’s 18th LCS warship for the US Navy completes acceptance trials The future USS Kingsville constructed by Austal USA, part of the Perth-based shipbuilder Austal, has successfully completed acceptance trials in the Gulf of Mexico for the U.S. Navy. During acceptance trials, comprehensive testing is conducted on the ship’s major systems and equipment in order…
Orthocell solidifies partnership with UWA Tissue regeneration technology developer Orthocell has executed an agreement with the University of Western Australia to exchange UWA’s entitlement to royalties for equity in Orthocell. The company will issue UWA 1.71 million shares in the company at a deemed price of 35 cents, placing the university among the top 20…
Australian Space Industry Capability Database to be launched The Space Industry Association of Australia has announced the Australian Space Industry Capability Database will launch to all users from mid-July 2023. The database will provide interactive data visualisations that demonstrate the scale and capability of the Australian space sector, including capability data, workforce data and detailed…
The Healthy Mummy to be sold through Woolworths Halo Food Co’s The Healthy Mummy sports and diet products are to be sold through Woolworths supermarkets nationally. The retailer will stock three THM powdered smoothie products from the first quarter of 2023. The sales value of the products to Halo is forecast to be $2.5 million…
Austal launches 115-metre high speed ferry Austal Philippines has successfully launched the 115-metre, high speed vehicle-passenger ferry Express 5 for MOLSLINJEN A/S of Denmark (pictured) The launch utilised a new vessel transportation system designed by Austal. The ‘Auto Express 115’ high-speed catamaran ferry is the largest ferry (by volume) constructed by an Austal shipyard and…
